Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis - Top-Institutions - MDSpire

Efficacy, long-term survival and safety of different PD-1 inhibitors plus chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis

  • By

  • Wen Sun

  • Yansha Liu

  • Hui Dong

  • Yun Huang

  • June 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology
  • #2

    Guangdong Provincial Clinical Research Center for Cancer
    Guangdong Provincial Clinical Research Center for Cancer

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology
  • #3

    Shengjing Hospital of China Medical University
    Shengjing Hospital of China Medical University

    Shenyang, Liaoning

    Key Differentiators

    • Oncology
  • #4

    Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
    Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology
  • #5

    Gustave Roussy Cancer Campus
    Gustave Roussy Cancer Campus

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

Original Source(s)

Related Content